Merck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its investigational, once-daily, oral, two-drug, single-tablet regimen of ...

Over the past three decades, there have been amazing advances in treating and preventing HIV. Subscribe to our newsletter for ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...

This new FDA-approved shot is designed to break down the barriers that have kept too many people from accessing PrEP.

Analysts believe that Gilead's new PrEP drug Yeztugo could reach peak sales of $4.5 billion. Not if GSK has anything to say ...

Mathematical models indicate that the worst-case scenario of the Trump administration’s HIV-related cuts could result in 3 ...

As more people live longer with HIV, Thomas Street at Quentin Mease Health Center is expanding services to address the ...

Trump’s “big beautiful” bill will also affect the pharmaceutical industry, while AI startups have pulled in the majority of ...

Elton John and Jeanine White, the mother of Ryan White, urge Congress not to cut funding for lifesaving HIV and AIDS programs ...

Discover how understanding your viral load and CD4 count puts you in control of HIV treatment and transforms confusing ...